High-dose therapy has become a common treatment for myeloma. The objectives of this
study were to estimate in a prospective, population-based setting the impact on survival of …

We describe clinical features and treatment results in 25 patients with solitary osseous
(SOP) and 18 patients with solitary extramedullary plasmacytoma (EMP). 41 patients were …

A survey was carried out among the European Group for Blood and Marrow Transplantation
(EBMT) centres to determine the incidence, risk factors, treatment and outcome of thrombotic …

Patients treated with allogeneic stem cell transplantation (allo-SCT) often develop ocular
complications. To investigate the ocular findings in young long-term survivors after allo-SCT …

The value of intensive therapy, including autologous stem cell transplantation, in newly
diagnosed myeloma patients> 60 years is not clear. We evaluated the impact of age (< 60 …

BACKGROUND AND OBJECTIVES: From 1994 to 1997 we conducted a population-based,
prospective study on intensive therapy in newly diagnosed symptomatic myeloma patients …

To the Editor: Intracoronary injection of bone marrow cells (BMC) has been introduced for
improvement of left ventricular (LV) function after acute myocardial infarction (AMI). In the …

This retrospective study examined the prevalence of and risk factors for cervical dysplasia
and genital human papillomavirus (HPV) infection in 89 female recipients of allogeneic stem …

Transplantation of peripheral blood progenitor cells (PBPCs) has largely replaced
autologous bone marrow transplantation. The same might occur in the allogeneic setting if …

OBJECTIVE: To evaluate the ophthalmologic complications in hematologic patients after
allogeneic stem cell transplantation (ASCT) without total body irradiation. DESIGN …